| A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis CK Stover, P Warrener, DR VanDevanter, DR Sherman, TM Arain, ... Nature 405 (6789), 962-966, 2000 | 1293 | 2000 |
| Detection and analysis of diverse herpesviral species by consensus primer PCR DR VanDevanter, P Warrener, L Bennett, ER Schultz, S Coulter, ... Journal of clinical microbiology 34 (7), 1666-1671, 1996 | 875 | 1996 |
| Decade-long bacterial community dynamics in cystic fibrosis airways J Zhao, PD Schloss, LM Kalikin, LA Carmody, BK Foster, JF Petrosino, ... Proceedings of the National Academy of Sciences 109 (15), 5809-5814, 2012 | 684 | 2012 |
| Cloning of the LamA3 gene encoding the alpha 3 chain of the adhesive ligand epiligrin. Expression in wound repair. MC Ryan, R Tizard, DR VanDevanter, WG Carter Journal of Biological Chemistry 269 (36), 22779-22787, 1994 | 347 | 1994 |
| Double minute chromosomes can be produced from precursors derived from a chromosomal deletion SM Carroll, ML DeRose, P Gaudray, CM Moore, ... Molecular and cellular biology, 1988 | 301 | 1988 |
| Covalent Binding of Antitumor Antibiotics in the Minor Groove of DNA. Mechanism of Action of CC-1065 and the Pyrrolo (1, 4) benzodiazepines LH Hurley, DR Needham-VanDevanter Accounts of Chemical Research 19 (8), 230-237, 1986 | 276 | 1986 |
| CFTR modulator theratyping: Current status, gaps and future directions JP Clancy, CU Cotton, SH Donaldson, GM Solomon, DR VanDevanter, ... Journal of Cystic Fibrosis 18 (1), 22-34, 2019 | 242 | 2019 |
| Elimination of extrachromosomally amplified MYC genes from human tumor cells reduces their tumorigenicity. DD Von Hoff, JR McGill, BJ Forseth, KK Davidson, TP Bradley, ... Proceedings of the National Academy of Sciences 89 (17), 8165-8169, 1992 | 191 | 1992 |
| Cystic fibrosis in young children: a review of disease manifestation, progression, and response to early treatment DR VanDevanter, JS Kahle, AK O’Sullivan, S Sikirica, PS Hodgkins Journal of Cystic Fibrosis 15 (2), 147-157, 2016 | 174 | 2016 |
| Amplified human MYC oncogenes localized to replicating submicroscopic circular DNA molecules. DD Von Hoff, DR Needham-VanDevanter, J Yucel, BE Windle, GM Wahl Proceedings of the National Academy of Sciences 85 (13), 4804-4808, 1988 | 157 | 1988 |
| Treatment with tobramycin solution for inhalation reduces hospitalizations in young CF subjects with mild lung disease TD Murphy, RD Anbar, LA Lester, SZ Nasr, B Nickerson, DR VanDevanter, ... Pediatric pulmonology 38 (4), 314-320, 2004 | 138 | 2004 |
| Risk factors for rate of decline in FEV1 in adults with cystic fibrosis MW Konstan, JS Wagener, DR VanDevanter, DJ Pasta, A Yegin, ... Journal of Cystic Fibrosis 11 (5), 405-411, 2012 | 127 | 2012 |
| State of progress in treating cystic fibrosis respiratory disease PA Flume, DR Van Devanter BMC medicine 10 (1), 88, 2012 | 123 | 2012 |
| Anti‐PcrV antibody in cystic fibrosis: A novel approach targeting Pseudomonas aeruginosa airway infection CE Milla, JF Chmiel, FJ Accurso, DR VanDevanter, MW Konstan, ... Pediatric pulmonology 49 (7), 650-658, 2014 | 118 | 2014 |
| Oral, inhaled, and intravenous antibiotic choice for treating pulmonary exacerbations in cystic fibrosis JS Wagener, L Rasouliyan, DR VanDevanter, DJ Pasta, WE Regelmann, ... Pediatric pulmonology 48 (7), 666-673, 2013 | 116 | 2013 |
| Antimicrobial susceptibility testing (AST) and associated clinical outcomes in individuals with cystic fibrosis: a systematic review R Somayaji, MD Parkins, A Shah, SL Martiniano, MM Tunney, JS Kahle, ... Journal of Cystic Fibrosis 18 (2), 236-243, 2019 | 98 | 2019 |
| Double minutes arise from circular extrachromosomal DNA intermediates which integrate into chromosomal sites in human HL-60 leukemia cells. DD Von Hoff, B Forseth, CN Clare, KL Hansen, D VanDevanter The Journal of clinical investigation 85 (6), 1887-1895, 1990 | 98 | 1990 |
| Fluctuations in airway bacterial communities associated with clinical states and disease stages in cystic fibrosis LA Carmody, LJ Caverly, BK Foster, MAM Rogers, LM Kalikin, RH Simon, ... PLoS One 13 (3), e0194060, 2018 | 91 | 2018 |
| Loss of DNA-membrane interactions and cessation of DNA synthesis in myeloperoxidase-treated Escherichia coli. H Rosen, J Orman, RM Rakita, BR Michel, DR VanDevanter Proceedings of the National Academy of Sciences 87 (24), 10048-10052, 1990 | 88 | 1990 |
| Standardized Treatment of Pulmonary Exacerbations (STOP) study: Physician treatment practices and outcomes for individuals with cystic fibrosis with pulmonary Exacerbations NE West, VV Beckett, R Jain, DB Sanders, JA Nick, SL Heltshe, ... Journal of Cystic Fibrosis 16 (5), 600-606, 2017 | 87 | 2017 |
